Loading...
Nordic Life Science 1
“We don’t have AstraZeneca. We don’t have Novo No
rdisk. It took a lot of time to get Norwegian investors interested, because it’s not property, it’s not oil and gas, and it’s not fish. Why should they go into such a risky business?” Jónas Einarsson, CEO, Radforsk BUSINESS // PROFILE